Kaposi's sarcoma-associated herpesvirus (KSHV) is a human oncogenic nuclear DNA 26 virus that expresses its genes using the host cell transcription and RNA processing 27 machinery. As a result, KSHV transcripts are subject to degradation by at least two host-28 mediated nuclear RNA decay pathways, PABPN1 and PAPα/γ-mediated RNA decay 29 (PPD) and an ARS2-dependent decay pathway. Here, we present global analyses of viral 30 transcript levels to further understand the roles of these decay pathways in KSHV gene 31 expression. Consistent with our recent report that the KSHV ORF57 protein increases 32 viral transcript stability by impeding ARS2-dependent decay, ARS2 knockdown has little 33 effect on viral gene expression 24 hours after lytic reactivation of wild-type virus. In 34 contrast, inactivation of PPD results in premature accumulation of late transcripts. The 35 up-regulation of late transcripts does not require the primary late gene-specific viral 36 transactivation factor, suggesting that cryptic transcription produces the transcripts that 37 then succumb to PPD. Remarkably, PPD inactivation has no effect on late transcripts at 38 their proper time of expression. We show that this time-dependent PPD evasion by late 39 transcripts requires the host factor NRDE2, which has previously been reported to protect 40 cellular RNAs by sequestering decay factors. From these studies, we conclude that KSHV 41 uses PPD to fine-tune the temporal expression of its genes by preventing their premature 42 accumulation. Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus 49 that causes Kaposi's sarcoma and other lymphoproliferative disorders. Nuclear 50 expression of KSHV genes results in exposure to at least two host-mediated nuclear RNA 51 decay pathways, PABPN1 and PAPα/γ-mediated RNA decay (PPD) and an ARS2-52 mediated decay pathway. Perhaps unsurprisingly, we previously found that KSHV uses 53 specific mechanisms to protect its transcripts from ARS2-mediated decay. In contrast, 54
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cases, ARS2 targets transcripts for degradation independently of NEXT or PPD/PAXT 116 (28, 29). These complex interconnections challenge efforts to uncover the degree of 117 independence or redundancy between nuclear RNA decay pathways. Nonetheless, 118 ARS2 clearly plays a central role in promoting the decay of a number of nuclear 119
transcripts. 120 121
Like their host counterparts, KSHV mRNAs are capped and polyadenylated, but most 122 KSHV genes are short and intronless (30, 31). Consequently, cellular RNA QC pathways 123 may degrade KSHV RNAs due to their similarity to PROMPTs. The essential 124 multifunctional KSHV ORF57 protein promotes viral transcript accumulation by increasing 125 nuclear RNA stability (32-45). We recently reported that viral transcripts are subject to 126 degradation by both PPD and an ARS2-dependent but NEXT-independent decay 127 pathway upon lytic reactivation of virus lacking ORF57 (29). Using pulse-chase assays 128
with an unstable form of the KSHV nuclear non-coding PAN RNA (PANΔENE), we further 129
showed that ORF57 preferentially protects viral transcripts from the ARS2-dependent 130 decay pathway (29). Interestingly, although viral transcripts succumb to PPD, ORF57 131 7 24 hours after lytic reactivation. ARS2 depletion resulted in few changes in viral gene 139 expression. However, PPD inactivation resulted in increased expression levels of several 140 viral genes. Interestingly, the most upregulated transcripts were late transcripts that are 141 otherwise expressed at ~48 hours after lytic reactivation. Our data suggest that PPD 142 prevents the premature accumulation of late transcripts which presumably arise as a 143 consequence of cryptic transcription. Notably, at their proper time of expression, PPD 144 inactivation has no effect on viral late transcripts, and the host factor NRDE2 is needed 145 for evasion of PPD. We conclude that KSHV exploits PPD to fine-tune the temporal 146 expression of viral genes by dampening steady-state levels of prematurely transcribed 147 late genes. 148
149

Results
150
151
PPD inactivation results in aberrant temporal expression of KSHV late genes 152 153
Our previous studies showed that viral RNAs were subject to both PPD and ARS2-154 mediated decay in the absence of ORF57 (29). ORF57 more potently protected viral 155 transcripts from ARS2-mediated decay than from PPD, suggesting that viral transcripts 156 succumb to PPD even in the presence of ORF57. To further characterize the role ofvalidated by western blot, qRT-PCR and/or loss of function assays (Fig 1B) . Lytic 162 reactivation was induced using doxycycline (dox) to promote expression of the dox-163 inducible RTA integrated into the iSLK host cell chromosomes and by the histone 164 deacetylase inhibitor sodium butyrate (NaB). We prepared libraries from RNA harvested 165 24 hours post induction (hpi), and the samples were subjected to high-throughput 166 sequencing ( Fig 1A) . Expression of several KSHV genes significantly increased in 167 samples depleted of PAPα/γ and in the dKD compared to samples treated with a control 168 siRNA. However, we observed minimal alterations in gene expression in the ARS2 169 knockdown samples, consistent with the idea that ARS2-mediated decay is inhibited by 170 ORF57 (Fig 1C and Table S1) . Surprisingly, the most upregulated genes (> 4-fold 171 change) upon PAPα/γ depletion and in the dKD were late genes, 76% and 70% 172 respectively (Fig 1D) . Typically, these KSHV late genes are not expressed at ~24 hpi in 173 these cells. These data suggest that KSHV exploits PAPα/γ to temporally control the 174 expression of late genes. 175 176 PPD/PAXT targets KSHV late genes for degradation 177
178
Our RNA-seq data show that PAPα/γ depletion results in increased expression of late 179 genes at 24 hpi and suggest that PPD controls the expression late genes that prematurely 180 arise due to cryptic transcription. To validate these observations and extend the findings 181 to additional PPD factors, we focused our attention on three KSHV late genes, ORF52, 182 ORF75, and K8.1. These genes were selected because they have different structural 183 features. ORF52 is a short transcript (395 base pairs (bp)) while ORF75 is a longtranscript (3890 bp). Both ORF52 and ORF75 are intronless, but K8.1 contains one intron. 185
In spite of these structural differences, the expression of each gene increased upon 186
PAPα/γ depletion at 24 hpi (Fig 2B, D and F ). None were affected by ARS2 depletion 187 alone. Similar results were obtained when the mRNA levels of these genes were 188 monitored by qRT-PCR (Fig 2C, E and G) . In principle, PAPα/γ knockdown may affect 189 gene expression independent of PPD due to its function in 3´-end formation. To confirm 190 the role of PPD, we tested whether depletion of PPD factors other than PAPα/γ caused a 191 similar phenotype. We depleted cells of the unique PPD/PAXT factor ZFC3H1 or the 192 exosome co-factor MTR4. Efficiency of knockdown was monitored by western blot, qRT-193 PCR and loss of function assays (Fig 2A) . Consistent with PPD inactivation, depletion of 194 ZFC3H1 or MTR4 also increased ORF75, ORF52 and K8.1 levels (Fig 2C, E and G) . factor that plays a critical role when the virus progresses from DNA replication to 207 expression of late genes. ORF24 binds to late gene promoters and recruits RNA 208 polymerase II (pol II) and other vTFs to the promoter region of late genes to induce their 209 expression. Because ORF24 mRNA levels were increased in cells depleted of PAPα/γ 210 and in the dKD at 24 hours post lytic reactivation (Fig 3A and 3B) , it is possible that PPD 211 inactivation results in ORF24 upregulation which drives the increased expression of late 212 genes. In this case, the effects of PPD on other late transcripts would result from a 213 secondary effect of ORF24 upregulation. To determine whether the increased expression 214 of late genes at 24 hpi is due to an upregulation of ORF24 upon PPD inactivation, we 215 used iSLK cells transfected with a bacmid encoding the viral genome in which ORF24 216 contains a point mutation, R328A, that renders it inactive (51). ORF24
R328A maintains the 217 interaction with pol II but is unable to interact with other vTAs resulting in strongly impaired 218 expression of late genes (Fig 3C) . If the up-regulation of late genes by PPD inactivation 219 is due to secondary effects of ORF24 upregulation, then the up-regulation will be 220 abrogated in the mutant virus. In contrast to this prediction, depletion of PPD components 221 PAPα/γ, MTR4 or ZFC3H1 resulted in increased mRNA levels of ORF52, ORF75 and 222
K8.1 in ORF24
R328A reactivated cells (Fig 3D, E and F) . Thus, the role of PPD in late gene 223 expression at 24 hpi is independent of ORF24 transactivation. Moreover, these data are 224 which occurs prior to 48 hpi in our iSLK WT cells. As PPD inactivation increases late gene 232 expression at 24 hpi, we tested whether the expression of late genes at 48 and 72 hpi is 233 also affected by PPD inactivation. Interestingly, at 48-or 72-hpi, PAPα/γ depletion had 234 no effect on the expression levels of the late genes tested (Fig 4A, B and C (Fig 4E) . Importantly, depletion of PAPα/γ 249 or ZFC3H1 had no effect in the production of infectious virus as the percentage of GFP 250 positive cells was similar to that of cells treated with a control siRNA (Fig 4E) . These data 251 suggest that the premature expression of late genes observed upon PPD inactivation 252 does not dramatically perturb the virus life cycle in cultured cells.
254
NRDE2 is needed for proper expression of late genes at 48 hours post lytic 255 reactivation 256 257
To determine how late transcripts avoid degradation at their proper time of expression, 258 we centered our attention on the human nuclear RNAi-defective 2 (NRDE2) protein. 259 NRDE2 localizes to nuclear speckles where it forms a 1:1 complex with MTR4 to inhibit 260 its recruitment and RNA degradation (54). Given this protective activity, we hypothesized 261 that KSHV uses NRDE2 to protect late transcripts from degradation. Therefore, we 262 depleted cells of PAPα/γ, NRDE2 ( Fig 5A) or both simultaneously and measured 263 expression levels of late transcripts by qRT-PCR at 24 hpi ( Fig 5B) or 48 hpi ( Fig 5C) . As 264 expected, PAPα/γ depletion resulted in increased expression levels of late genes at 24 265 hpi but no effect at 48 hpi ( Fig 5B and C) (green bars). In contrast, NRDE2 depletion 266 caused a reduction in expression levels of all late transcripts at 48 hpi but had no effect 267 at 24 hpi (Fig 5B and C) (orange bars) suggesting that NRDE2 protects KSHV late 268 transcripts from PPD-mediated degradation at 48 hpi. Importantly, co-depletion of PAPα/γ 269 and NRDE2 restored late transcripts levels to that of control siRNA treated cells ( Fig 5C) 
270
(blue bars). We conclude that after viral genome replication, the host NRDE2 protects 271
KSHV RNAs from PPD. 272
Discussion 277
278
KSHV transcripts are subject to degradation by at least two host-mediated nuclear RNA 279 decay pathways, PPD and an ARS2-dependent decay pathway (29). KSHV ORF57 280 increases viral transcript stability by protecting RNAs from ARS2-dependent decay (29). 281
Our work here suggests that KSHV uses PPD to post-transcriptionally control the 282 premature accumulation of late transcripts during the early stages of the viral lytic phase. 283
In the context of PPD inactivation, late transcripts aberrantly accumulate at 24 hpi (Fig 1  284 and 2), but the premature production of late transcripts does not require functional 285 ORF24. Therefore, the transcripts do not accumulate as a secondary consequence of the 286 up-regulation of the late gene inducer ORF24 (Fig 3) . Presumably, the open chromatin 287 and high transcription of the viral genome during early lytic phase allows low-level cryptic 288 transcription of late genes ( Fig 6A) . The transcripts are eliminated by PPD, so no proteins 289 are produced. At their proper time of expression, late transcripts evade PPD by an 290 NRDE2-dependent mechanism (Fig 5) . Thus, we propose that KSHV fine-tunes temporal 291 expression of its genes using a specific host RNA quality control pathway. 292
293
Increasing evidence shows that RNA decay pathways play a critical role in controlling 294 viral infection (29, 55-57). The nuclear RNA decay factors, MTR4 and ZCCHC7, 295 translocate to the cytoplasm where they promote exosome-mediated degradation of viral 296 transcripts of multiple RNA virus (55). In the case of KSHV, the ORF57 protein protects 297 viral transcript from ARS2-dependent decay by preventing MTR4 recruitment (29). In 298 these examples, the viruses must circumvent the RNA QC machinery to properly expressits genes. Here we propose that the virus hijacks PPD activity to fine-tune the temporal 300 expression of its genes. That is, KSHV allows PPD to degrade late transcripts that arise 301 as a consequence of cryptic transcription at 24 hpi (Fig 2 and 6A) . However, at the 302 appropriate time of expression, KSHV blocks PPD so late genes are expressed (Fig 4A-303 C). The long co-evolution of herpesviruses with their specific hosts has selected for 304 sophisticated host-pathogen interactions. These contrasting interactions with the host 305 RNA QC pathways represent intriguing examples of virus-host co-evolution that ensures 306 KSHV expresses its genes in a precise temporal manner. 307
308
Our observations also contribute to the understanding of the distinctions between host 309 PPD, PAXT and ARS2-mediated decay processes. While it seems likely that PPD and 310 PAXT represent the same pathway, it has been reported that ARS2 is involved in PAXT 311 recruitment to unstable transcripts (20). However, in the context of KSHV infection, PPD 312
and an ARS2-mediated decay pathway appear to be independent pathways. For 313 example, simultaneous depletion of PAPα/γ and ARS2 resulted in greater stabilization of 314 viral transcripts than depletion of either alone during iSLK-DORF57 reactivation (29) . 315 Furthermore, we show that depletion of PAPα/γ enhances specific viral genes, while 316 ARS2 depletion has little effect (Figs 1 and 2) . Importantly, we show that depletion of 317 ZFC3H1, a PAXT component, mimics PAPα/γ depletion as the same group of viral genes 318 are upregulated (Fig 2) . Overall, these data suggest that PPD and PAXT represent the 319 same process, but ARS2 is not absolutely required for PPD/PAXT-mediated decay. 320
However, more work is needed to completely define the overlap and independence of 321 these RNA QC pathways. 322 PPD inactivation results in the aberrant temporal expression of KSHV late genes. 324
However, this atypical expression of late genes does not affect viral genome replication 325 or production of infectious virions in our iSLK cells (Fig 4D & E) . Several reasons may 326 explain this unexpected result. Even though PAP knockdown increases late gene 327 expression levels relative to cells treated with a control siRNA, the expression levels 328 reached may not be high enough to affect viral fitness. Indeed, expression of late genes 329 at 48 or 72 hpi is considerably higher than at 24 hpi (Fig 4A-C) . Consequently, the levels 330 of late genes reached at 24 hpi may not be sufficient to disrupt viral physiology in iSLK 331 cells. Another possibility is that the virus uses PPD to keep expression levels of late genes 332 low during early phases of lytic infection as these may elicit an immune response in an 333 infected organism. Indeed, circulating anti-K8.1 antibodies detected in Kaposi's sarcoma 334 patients support that this PPD-restricted gene elicits an immune response (58-60). If the 335 role of PPD is to keep potentially immunogenic genes low, we would miss this phenotype 336 in a cell culture system. 337
338
Late transcripts evade PPD during late phases of replication, but the mechanism of PPD 339 evasion is not completely understood. Our data show that the host factor NRDE2 is 340 required for evasion of PPD during late infection (Fig 5) . NRDE2 function is linked to its 341 residence in nuclear speckles, where it interacts with MTR4 to inhibit its activity thereby 342 protecting speckle-associated mRNAs (54). As expression of KSHV late genes occurs at 343 the onset of viral genome replication, we speculate that NRDE2 re-localizes to replication 344 compartments (Fig 6B) . When this occurs, NRDE2 interacts with MTR4 preventing theevade PPD and are properly expressed. Supporting this idea, HSV1 replication 347 compartments coalesce with nuclear speckles (61), but whether this occurs in KSHV has 348 yet to be tested. targeting PAPα and PAPγ (PAPα/γ), ARS2 or both PAPα/γ and ARS2 combined (dKD) 367 using the concentrations specified in the siRNA transfection section. Total RNA was 368 harvested three days after siRNA transfection and 24 hours post lytic reactivation. Oneμg of intact total RNA per condition was used to make stranded mRNA-seq libraries with 370 the Stranded mRNA-Seq kit (KAPA Biosystems) as per manufacturer's protocol. The 371 strand-specific single-end RNA-sequencing was performed using Illumina HiSeq2500. 372
373
RNA-seq analysis 374 375
The qualities of sequencing reads were evaluated using NGS QC Toolkit (v2. 
org/morpheus/). 394
The data discussed in this publication have been deposited in NCBI's Gene Expression 395
Omnibus (68) 
transcriptase (New England Biolabs). Real-time reactions used iTaq Universal SYBR 427
Green Supermix (Biorad). Primers are listed in Table S3 . 428
429
KSHV Reactivation and Infection 430 431
Lytic reactivation of iSLK derived cells was achieved by adding doxycycline (1 µg/ml) and 432 NaB (1mM). Tissue culture supernatants from iSLK WT cells were collected at 0, 8, 12, 433 24, 48 and 72 hpi, centrifuged for 5 min at 1000 x g and passed through a 0.45 um filter. 434
Polybrene was added (8 µg/mL final concentration), and 300 µL were applied to HEK293 435 cells grown in a 12-well plate. Cells were centrifuged for 45 min at 30°C and then 436 incubated in 5% CO2 at 37°C for 2 hours. After this, media was replaced and cells were 437 analyzed by flow cytometry 24 hours later.
Western Blotting 440 441
Cells were lysed in buffer containing 100 mM NaCl, 50 mM Tris-HCl pH 7.4, 1% Triton X-442 100, 1X Protease Inhibitor cocktail (PIC) (Calbiochem) and 250 μM PMSF. Proteins were 443 resolved by SDS-PAGE and analyzed by western blot using standard procedures. 
